Skip to content Skip to left sidebar Skip to footer

Bridge Access Program Update

Bridge Access Program Update

Thank you for your continued efforts in ensuring that Philadelphia community members have access to the COVID-19 vaccine. We regret to inform you that the federally funded Bridge Access Program (BAP) has ended before the original closure date of December 31st, 2024. This difficult decision was reached due to congressional rescissions in the FY 2024 Further Consolidated Appropriations Act. With the FDA’s approval of the updated COVID-19 vaccines for the 2024 – 2025 season, all previous COVID-19 vaccines are now unauthorized for use and should not be administered.  

To minimize the risk of vaccine administration errors, providers should:  

  • Remove all 2023–2024 COVID-19 vaccines from storage units immediately, even if they are not expired.  
  • Return all unused 2023–2024 COVID-19 vaccines to McKesson using the normal process for returning spoiled/expired vaccines in PhilaVax. Use this guide to assist you in the return process. 
    • Mark the reason as “Other” then in the comment box type in Deauthorized.

Next Steps for Vaccinating Uninsured & Underinsured Patients

The FDA has approved and authorized the 2024-2025 COVID-19 vaccines from Pfizer and Moderna.  

What to Know 

  • Everyone ages 6 months and older should get a 2024-2025 COVID-19 vaccine.  
  • 2024-2025 COVID-19 vaccine products are not available through the Bridge Access Program. 
  • The 2023–2024 Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use.  

The Immunization Program has been awarded limited funds to allow providers previously enrolled in the Bridge Program to order a small quantity of the updated 2024-2025 COVID-19 vaccine. Please note that these doses are limited. Review your site’s usage over the 2023-2024 season and order small amounts of COVID-19 vaccine. Large orders may be reduced due to our limited supply. You will be notified when ordering is open in the next few weeks.  

We value your efforts in vaccinating underinsured and uninsured adults and want to express our gratitude for your continued participation in our programs. Ensure you are receiving email advisories from vaccines@phila.gov, our primary means for disseminating information to our providers. If you or your colleagues are not receiving advisories, email vaccines@phila.gov.